5clinical and safety considerations, Clinical considerations, Safety considerations – Philips M3860A User Manual
Page 43
5-1
P
h
ili
ps
Me
dic
a
l
Sy
s
tem
s
5
5
Clinical and Safety Considerations
Clinical Considerations
Indications
The HeartStart FR2+ is indicated for use on victims of sudden cardiac arrest
exhibiting the following signs:
Unresponsiveness
Absence of normal breathing
The HeartStart FR2+ is intended for use by personnel who have been
trained in its operation. The user should be qualified by training in basic life
support, advanced life support, or other physician-authorized emergency
medical response.
N O T E
:
At the discretion of emergency care personnel, the M3860A FR2+
with ECG display enabled can also be used with the FR2+ ECG
assessment module to display the rhythm of a responsive or breathing
patient, regardless of age. There are no known contraindications to use of
the FR2+ ECG assessment module.
Contraindications
The HeartStart FR2+ is contraindicated for use (should not be used) on
patients who show either of the following signs:
Responsiveness
Presence of normal breathing
Safety Considerations
You should be aware of the safety concerns listed here when you use the
HeartStart FR2+. Read them carefully. You will also see some of these
messages in other parts of this manual. The messages are labeled Danger,
Warning, or Caution.
D A N G E R
— immediate hazards that will result in personal injury or
death.
W A R N I N G
— conditions, hazards, or unsafe practices that can
result in serious personal injury or death.